571 Design of a platform technology for systemic delivery of siRNA to tumours using rolling circle transcription.
http://www.nature.com/ncomms/2015/150806/ncomms8930/full/ncomms8930.html
570 Comprehensive genomic profiles of small cell lung cancer.
http://www.nature.com/nature/journal/v524/n7563/full/nature14664.html
569 A paclitaxel-loaded recombinant polypeptide nanoparticle outperforms Abraxane in multiple murine cancer models.
http://www.nature.com/ncomms/2015/150804/ncomms8939/full/ncomms8939.html
568 Cancer chemoprevention: Evidence of a nonlinear dose response for the protective effects of resveratrol in humans and mice.
http://stm.sciencemag.org/content/7/298/298ra117
567 Loss of ATM accelerates pancreatic cancer formation and epithelial–mesenchymal transition.
http://www.nature.com/ncomms/2015/150729/ncomms8677/full/ncomms8677.html
566 Cancer in the parasitic protozoans Trypanosoma brucei and Toxoplasma gondii.
http://www.pnas.org/content/112/29/8835.abstract
565 The cell cycle regulator 14-3-3σ opposes and reverses cancer metabolic reprogramming.
http://www.nature.com/ncomms/2015/150716/ncomms8530/full/ncomms8530.html
564 Conversion of abiraterone to D4A drives anti-tumour activity in prostate cancer.
http://www.nature.com/nature/journal/v523/n7560/full/nature14406.html
563 Progesterone receptor modulates ERα action in breast cancer.
http://www.nature.com/nature/journal/v523/n7560/full/nature14583.html
562 Reserve stem cells: Differentiated cells reprogram to fuel repair, metaplasia, and neoplasia in the adult gastrointestinal tract (Review).
http://stke.sciencemag.org/content/8/385/re8.abstract
561 Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity.
http://www.nature.com/nature/journal/v523/n7559/full/nature14404.html
560 Glypican-1 identifies cancer exosomes and detects early pancreatic cancer.
http://www.nature.com/nature/journal/v523/n7559/full/nature14581.html
559 MYC regulates the core pre-mRNA splicing machinery as an essential step in lymphomagenesis.
http://www.nature.com/nature/journal/v523/n7558/full/nature14351.html
558 Grb2 monomer–dimer equilibrium determines normal versus oncogenic function.
http://www.nature.com/ncomms/2015/150624/ncomms8354/full/ncomms8354.html
557 Inherited coding variants at the CDKN2A locus influence susceptibility to acute lymphoblastic leukaemia in children.
http://www.nature.com/ncomms/2015/150624/ncomms8553/full/ncomms8553.html
556 Epigenetic therapy overcomes treatment resistance in T cell prolymphocytic leukemia.
http://stm.sciencemag.org/content/7/293/293ra102
555 Detection of human brain cancer infiltration ex vivo and in vivo using quantitative optical coherence tomography.
http://stm.sciencemag.org/content/7/292/292ra100
554 Active targeting of chemotherapy to disseminated tumors using nanoparticle-carrying T cells.
http://stm.sciencemag.org/content/7/291/291ra94
553 Combining three antibodies nullifies feedback-mediated resistance to erlotinib in lung cancer.
http://stke.sciencemag.org/content/8/379/ra53.abstract
552 α-Enolase–targeted lipid nanoparticles containing chemotherapeutic drugs are effective for the treatment of colorectal cancer.
http://stm.sciencemag.org/content/7/290/290ra91.abstract
|
